PGNY
Progyny Inc.
Company Overview
| Mkt Cap | $1.66B | Price | $25.86 |
| Volume | 1.16M | Change | +4.15% |
| P/E Ratio | 30.6 | Open | $24.59 |
| Revenue | $1.2B | Prev Close | $24.83 |
| Net Income | $54.3M | 52W Range | $13.86 - $27.25 |
| Div Yield | N/A | Target | $28.78 |
| Overall | 76 | Value | 70 |
| Quality | -- | Technical | 83 |
No chart data available
About Progyny Inc.
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Latest News
Progyny (PGNY) Receives a Buy from Jefferies
Truist Financial Sticks to Their Hold Rating for Progyny (PGNY)
Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), Halozyme (HALO) and Progyny (PGNY)
Hartshead Resources NL Secures Shareholder Approval for Key Resolutions
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PGNY | $25.86 | +4.1% | 1.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |